Literature DB >> 21731134

Sleep neurobiology from a clinical perspective.

Rodrigo A España1, Thomas E Scammell.   

Abstract

Many neurochemical systems interact to generate wakefulness and sleep. Wakefulness is promoted by neurons in the pons, midbrain, and posterior hypothalamus that produce acetylcholine, norepinephrine, dopamine, serotonin, histamine, and orexin/hypocretin. Most of these ascending arousal systems diffusely activate the cortex and other forebrain targets. NREM sleep is mainly driven by neurons in the preoptic area that inhibit the ascending arousal systems, while REM sleep is regulated primarily by neurons in the pons, with additional influence arising in the hypothalamus. Mutual inhibition between these wake- and sleep-regulating regions likely helps generate full wakefulness and sleep with rapid transitions between states. This up-to-date review of these systems should allow clinicians and researchers to better understand the effects of drugs, lesions, and neurologic disease on sleep and wakefulness.

Entities:  

Keywords:  Waking; arousal; dorsal raphe nucleus; locus coeruleus; thalamus; tuberomammillary nucleus; ventrolateral preoptic area

Mesh:

Year:  2011        PMID: 21731134      PMCID: PMC3119826          DOI: 10.5665/SLEEP.1112

Source DB:  PubMed          Journal:  Sleep        ISSN: 0161-8105            Impact factor:   5.849


  234 in total

1.  Local sleep and learning.

Authors:  Reto Huber; M Felice Ghilardi; Marcello Massimini; Giulio Tononi
Journal:  Nature       Date:  2004-06-06       Impact factor: 49.962

Review 2.  Histamine H3 receptors and sleep-wake regulation.

Authors:  Jian-Sheng Lin; Olga A Sergeeva; Helmut L Haas
Journal:  J Pharmacol Exp Ther       Date:  2010-09-23       Impact factor: 4.030

3.  Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ.

Authors:  Denis Burdakov; Oleg Gerasimenko; Alexei Verkhratsky
Journal:  J Neurosci       Date:  2005-03-02       Impact factor: 6.167

4.  A putative flip-flop switch for control of REM sleep.

Authors:  Jun Lu; David Sherman; Marshall Devor; Clifford B Saper
Journal:  Nature       Date:  2006-05-10       Impact factor: 49.962

5.  Modafinil binds to the dopamine uptake carrier site with low affinity.

Authors:  E Mignot; S Nishino; C Guilleminault; W C Dement
Journal:  Sleep       Date:  1994-08       Impact factor: 5.849

6.  Dopaminergic role in stimulant-induced wakefulness.

Authors:  J P Wisor; S Nishino; I Sora; G H Uhl; E Mignot; D M Edgar
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

7.  Importance of the ventrolateral region of the periaqueductal gray and adjacent tegmentum in the control of paradoxical sleep as studied by muscimol microinjections in the cat.

Authors:  J P Sastre; C Buda; K Kitahama; M Jouvet
Journal:  Neuroscience       Date:  1996-09       Impact factor: 3.590

8.  Acute effects of transdermal nicotine on sleep architecture, snoring, and sleep-disordered breathing in nonsmokers.

Authors:  D G Davila; R D Hurt; K P Offord; C D Harris; J W Shepard
Journal:  Am J Respir Crit Care Med       Date:  1994-08       Impact factor: 21.405

9.  Activation of c-fos in GABAergic neurones in the preoptic area during sleep and in response to sleep deprivation.

Authors:  Hui Gong; Dennis McGinty; Ruben Guzman-Marin; Keng-Tee Chew; Darya Stewart; Ronald Szymusiak
Journal:  J Physiol       Date:  2004-02-13       Impact factor: 5.182

Review 10.  Circadian integration of metabolism and energetics.

Authors:  Joseph Bass; Joseph S Takahashi
Journal:  Science       Date:  2010-12-03       Impact factor: 47.728

View more
  68 in total

Review 1.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

Review 2.  Comorbid Insomnia and Psychiatric Disorders: An Update.

Authors:  Khurshid A Khurshid
Journal:  Innov Clin Neurosci       Date:  2018-04-01

3.  What optogenetic stimulation is telling us (and failing to tell us) about fast neurotransmitters and neuromodulators in brain circuits for wake-sleep regulation.

Authors:  Elda Arrigoni; Clifford B Saper
Journal:  Curr Opin Neurobiol       Date:  2014-07-26       Impact factor: 6.627

Review 4.  Neurobiology of sleep (Review).

Authors:  Cristian Falup-Pecurariu; Ștefania Diaconu; Diana Țînț; Oana Falup-Pecurariu
Journal:  Exp Ther Med       Date:  2021-01-25       Impact factor: 2.447

5.  Self-reported sleep disturbances associated with procedural learning impairment in adolescents at ultra-high risk for psychosis.

Authors:  Jessica R Lunsford-Avery; Derek J Dean; Vijay A Mittal
Journal:  Schizophr Res       Date:  2017-03-16       Impact factor: 4.939

6.  Inability to replicate cerebrospinal fluid histamine deficits in the primary hypersomnias: a back to the drawing board moment.

Authors:  David B Rye
Journal:  Sleep       Date:  2012-10-01       Impact factor: 5.849

7.  Optogenetic stimulation of locus ceruleus neurons augments inhibitory transmission to parasympathetic cardiac vagal neurons via activation of brainstem α1 and β1 receptors.

Authors:  Xin Wang; Ramón A Piñol; Peter Byrne; David Mendelowitz
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

Review 8.  Neuronal Mechanisms for Sleep/Wake Regulation and Modulatory Drive.

Authors:  Ada Eban-Rothschild; Lior Appelbaum; Luis de Lecea
Journal:  Neuropsychopharmacology       Date:  2017-12-05       Impact factor: 7.853

9.  Heterogeneous responses of nucleus incertus neurons to corticotrophin-releasing factor and coherent activity with hippocampal theta rhythm in the rat.

Authors:  Sherie Ma; Anna Blasiak; Francisco E Olucha-Bordonau; Anthony J M Verberne; Andrew L Gundlach
Journal:  J Physiol       Date:  2013-05-13       Impact factor: 5.182

Review 10.  Orexin (hypocretin) receptor agonists and antagonists for treatment of sleep disorders. Rationale for development and current status.

Authors:  Michihiro Mieda; Takeshi Sakurai
Journal:  CNS Drugs       Date:  2013-02       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.